Arterial and pulmonary arterial concentrations of the enantiomers of bupivacaine after epidural injection in elderly patients

被引:7
|
作者
Sharrock, NE
Mather, LE
Go, G
Sculco, TP
机构
[1] Hosp Special Surg, Dept Anesthesiol, New York, NY 10021 USA
[2] Hosp Special Surg, Dept Orthopaed Surg, New York, NY 10021 USA
[3] Univ Sydney, Royal N Shore Hosp, Dept Anaesthesia & Pain Management, St Leonards, NSW 2065, Australia
来源
ANESTHESIA AND ANALGESIA | 1998年 / 86卷 / 04期
关键词
D O I
10.1097/00000539-199804000-00025
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Bupivacaine HCl is a 50:50 racemic mixture of the levo [S(-)] and dex [R(+)] enantiomers. The R(+) enantiomer exhibits greater cardiac tissue binding and toxicity. To determine whether the lung exhibits selective uptake of one of the enantiomers of bupivacaine, we measured pulmonary artery and radial artery blood concentrations of the two enantiomers after a lumbar epidural injection of 20 mL of 0.75% bupivacaine in 10 elderly patients undergoing one-stage bilateral total knee arthroplasty. Significantly lower concentrations of R(+) than S(-) were noted in both pulmonary artery and arterial blood. Both enantiomers were absorbed by the lung to a similar extent within the first 5 min after epidural injection (extraction ratio approximately equal to 0.1 or 10%). Mean time of maximal concentration (T-max) was 6 min. In 3 of the 10 patients, T-max occurred in 1-3 min. We conclude that the lung absorbs both the R(+) and S(-) enantiomers of bupivacaine to a similar extent after epidural injection and that this is of doubtful clinical significance. This study also suggests that peak concentrations of bupivacaine may occur earlier after epidural injection in certain elderly patients than previously believed. Implications: In the first 5 min after epidural injection, approximately 10% of the local anesthetic bupivacaine was absorbed by the lung. Absorption of the two enantiomers (mirror images) of bupivacaine were similar. Lung absorption of bupivacaine is unlikely to influence local anesthetic toxicity.
引用
收藏
页码:812 / 817
页数:6
相关论文
共 50 条
  • [21] Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension
    Seiichiro Sakao
    Norbert F. Voelkel
    Nobuhiro Tanabe
    Koichiro Tatsumi
    Respiratory Research, 16
  • [22] PROGRESS OF PATIENTS WITH PULMONARY ATRESIA AFTER SYSTEMIC TO PULMONARY ARTERIAL SHUNTS
    CALDER, AL
    CHAN, NS
    CLARKSON, PM
    KERR, AR
    NEUTZE, JM
    ANNALS OF THORACIC SURGERY, 1991, 51 (03): : 401 - 407
  • [23] Safety and efficacy of sitaxsentan in elderly patients with Pulmonary Arterial Hypertension (PAH)
    Vachiery, J. L.
    Sandoval-Zarate, J.
    Keogh, A.
    Kramer, M. R.
    Barst, R. J.
    Naeije, R.
    EUROPEAN HEART JOURNAL, 2006, 27 : 623 - 623
  • [24] Hoarseness after pulmonary arterial stenting and occlusion of the arterial duct
    Assaqqat, M
    Siblini, G
    Al Fadley, F
    CARDIOLOGY IN THE YOUNG, 2003, 13 (03) : 302 - 304
  • [26] Pulmonary arterial hypertension in the elderly: Clinical perspectives
    Rothbard, Nicholas
    Agrawal, Abhinav
    Fischer, Conrad
    Talwar, Arunabh
    Sahni, Sonu
    CARDIOLOGY JOURNAL, 2020, 27 (02) : 184 - 193
  • [27] Arterial carboxyhemoglobin concentrations as a predictor of chemosensitivity in elderly patients with advanced lung cancer
    Yasuda, H
    Yamaya, M
    Nakayama, K
    Ebihara, S
    Asada, M
    Sasaki, T
    Inoue, D
    Yoshida, M
    Kubo, H
    Sasaki, H
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2006, 54 (02) : 373 - 375
  • [28] APPEARANCE AND REGRESSION OF PULMONARY ARTERIAL LESIONS AFTER REPEATED INTRAVENOUS INJECTION OF GAS
    BOEREMA, B
    JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1965, 89 (02): : 741 - +
  • [29] PLASMA-CONCENTRATIONS OF BUPIVACAINE IN NEWBORN AFTER EPIDURAL MATERNAL ADMINISTRATION
    BRUGGUEROLLE, B
    GIAUFRE, E
    RASTELLO, C
    VERDOT, JJ
    THERAPIE, 1993, 48 (01): : 60 - 61
  • [30] Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension
    Hoeper, MM
    Galiè, N
    Murali, S
    Olschewski, H
    Rubenfire, M
    Robbins, IM
    Farber, HW
    McLaughlin, V
    Shapiro, S
    Pepke-Zaba, J
    Winkler, J
    Ewert, R
    Opitz, C
    Westerkamp, V
    Vachiéry, JL
    Torbicki, A
    Behr, J
    Barst, RJ
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (03) : 341 - 344